FORMULATION DEVELOPMENT AND CHARACTERIZATION OF ORAL HYPOGLYCEMIC AGENT LOADED SOLID LIPID NANOPARTICLES

Abstract

Solid Lipid Nanoparticles has been used as suitable carriers for delivery of drug with poor solubility. Nateglinide was taken as model antidiabetic drug was incorporated in Solid lipid Nanoparticles (SLNs) loaded with were prepared by a hot homogenization method using cephalin and lecithin as lipids and Tween 80 as stabilizer. Characterization and evaluation studies such as particle size measurement, poly dispersity index, Zeta potential, entrapment and loading capacity, Stability studies, in vitro release studies were done to ensure the quality Solid lipid Nanoparticles. Scanning Electron Microscopy showed the SLN particles were spherical shape in the size between 85 – 120 nm and the poly dispersity indexes were 0.148 to 0.227. The zeta potential was - 27.1 ± 2.5 to −36.1 ± 2.1 mV. The entrapment efficiency (EE %) and drug loading capacity (DL %) determined were 80.4 ± 4.2 % to 92.3 ± 7.2 %. Differential scanning calorimetry (DSC) thermo grams revealed the stability of SLNs with no tendency of recrystallisation. in situ and externally sink method revealed the release pattern of drug was found to follow fick’s and Higuchi equations. Results of stability evaluation showed a relatively long-term stability after storage at 5°C and 30°C for 12 weeks. In this formulation increase in concentration of lipid content has increased the entrapment efficiency of SLN. In conclusion, SLNs with small particle size, excellent physical stability, high entrapment efficiency, good loading capacity for diabetic drug can be maintaining blood glucose level normally for long time.